<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In addition to the known effects on drug metabolism and response, functional polymorphisms of genes coding for <z:chebi fb="0" ids="35703">xenobiotic</z:chebi>-metabolizing enzymes (XME) play a role in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Genes coding for XME act as low-penetrance genes and confer modest but consistent and significant risks for a variety of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> related to the interaction of environmental and genetic factors </plain></SENT>
<SENT sid="2" pm="."><plain>Consistent evidence supports a role for polymorphisms of the <z:chebi fb="0" ids="38559">cytochrome P450</z:chebi> CYP2C9 gene as a protecting factor for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> susceptibility </plain></SENT>
<SENT sid="3" pm="."><plain>It has been shown that CYP2C8 and CYP2C9 overlap in substrate specificity </plain></SENT>
<SENT sid="4" pm="."><plain>Because CYP2C8 has the common functional polymorphisms rs11572080 and rs10509681 (CYP2C8*3), it could be speculated that part of the findings attributed to CYP2C9 polymorphisms may actually be related to the presence of polymorphisms in the CYP2C8 gene </plain></SENT>
<SENT sid="5" pm="."><plain>Nevertheless, little attention has been paid to the role of the CYP2C8 polymorphism in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>We analyzed the influence of the CYP2C8*3 allele in the risk of developing <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in genomic DNA from 153 individuals suffering <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and from 298 age- and gender-matched control subjects </plain></SENT>
<SENT sid="7" pm="."><plain>Our findings do not support any effect of the CYP2C8*3 allele (OR for carriers of functional CYP2C8 alleles = 0.50 (95% CI = 0.16-1.59; p = 0.233) </plain></SENT>
<SENT sid="8" pm="."><plain>The absence of a relative risk related to CYP2C8*3 did not vary depending on the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> site </plain></SENT>
<SENT sid="9" pm="."><plain>We conclude that the risk of developing <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> does not seem to be related to the commonest functional genetic variation in the CYP2C8 gene </plain></SENT>
</text></document>